people on the move
XenoGesis
Nottingham, UK-based Clinical Research Organisation (CRO) XenoGesis has appointed Graham Trevitt Director of External Projects.
Graham previously worked as Director of Medicinal Chemistry at Almac Discovery where he was responsible for medicinal chemistry strategy, including integration of DMPK properties into compound design.
XenoGesis specialises in contract preclinical drug metabolism and pharmacokinetics (DMPK) work, quantitative bioanalysis and expert interpretation. The small CRO employs 14 staff at its site in BioCity Nottingham.